Wang Yingjun, Ph.D., professor, doctoral supervisor. She is the academic pacemaker of Biomedical Engineering, Director of National Engineering Center for Tissue Restoration and Reconstruction, President of Chinese Society of Biomaterials，Vice President of Chinese Materials Research Society. Elected as the Fellow of Biomaterials Science and Engineering of International Union of Societies for Biomaterials Science and Engineering in 2007, elected as the Academician of the Chinese Academy of Engineering in 2015, elected as the Academician of Asia Pacific Academy of Materials in 2019.
Prof Wang is the academic pacemaker of National Engineering Center for Tissue Restoration and Reconstruction. The center has a strong research team of more than 220 R&D personnels from multiple majors, such as material science, biomedical engineering, clinical medicine, etc. covers biomedical materials, tissue engineering and regenerative medicine, biomedical information and medical image, technical and equipment of precision medicine, which includes four academicians, three Distinguished “Yangtze River” Scholars, six National Distinguished Young Scholars, two National Excellent Young Scholars, two fellows of the International Society for Biomaterials Science and Engineering, two fellows of the International Institute of Electrical and Electronics Engineering. The center owns one innovation team of the Ministry of Education, two innovation teams of the Natural Science Foundation of Guangdong Province. It has already set up a complete system from undergraduate to post-doctoral on Engineering, Science and Medical Science.
Otherwise, a team of technical transformation and support has been developed which has 120 technicist with engineering and marketing experience. Experts from well-known universities hospitals around the world, technicist and managers of the leading enterprises have been invited to the center as guest staff, including the academicians, Distinguished “Yangtze River” Scholars, six National Distinguished Young Scholars.The center has undertaken hundreds of funding supports from the government including those top grants such as 973 Program/National Key R&D Program, 863 Program, Key Program of NFSC, with total funding of 200 millions. The research achievements has been issued more than 20 awards, including the 1st and 2nd prize of the National Natural Science Award, the 2nd prize of the National Technical Invention, the 1st and 2nd prize of the National Teaching Achievement. 600 papers have been published, more than 400 are indexed by SCI/EI. The center has the first Overseas Expertise Introduction Center for Discipline Innovation for Novel Biomedical Materials and Tissue Restoration of its kind in China. In addition, the center has built strong ties with world-class unversities including Nanyang Technological University, Columbia University, Johns Hopkins University, and University of Glasgow etc.
The center is striving for innovation of its system in aim to establishing a “open, diverse, dynamic, and efficient’ management mode. It has launched the Guangdong Provincial Innovative Alliance of Industry, as well as National Collaborative Innovation Center for Human Tissue Recontruction in 2018. The center has been working on setting up novel collabrative connection of Medicine-Industry-Research-Enterprise-Regulation, and shortening the development period of high-end medical devices and made important contributions and impacts to the national economic development in the fields of medicine and health.
王迎军，教授，博导，生物医学工程学科带头人，国家人体组织功能重建工程技术研究中心主任。兼任中国生物材料学会理事长，中国材料研究学会副理事长。国家973重大基础研究项目首席科学家，2007年当选国际生物材料科学与工程联合院FELLOW，2015年当选中国工程院院士,2019当选亚太材料科学院院士。
以王迎军教授为学术带头人的国家人体组织功能重建工程技术研究中心，现有各类研究人员220多人，来自多个学科专业，如材料科学与工程、生物医学工程、临床医学等，主要研究方向涉及生物医学材料、组织工程与再生医学、生物医学信息与医学影像、精准医疗技术与装备等。包括院士4人、长江学者特聘教授3人，国家杰出青年基金获得者6人、优秀青年基金获得者2人及其他各类人才20余人；拥有1个教育部创新团队、2个广东省自然科学基金创新团队和“十一五”国家科技计划执行优秀团队，组建了重大协同创新任务战略研究团队，具有工科、理科、医学的本硕博、博士后完整人才培养体系。此外，团队还培养了一支技术转化和支撑队伍，有工程经验丰富和市场推介能力强的技术人员120余人，以及来自国内外知名高校、医院的专家与龙头企业的技术、管理人员等组成的客座人员队伍，形成了以院士、“长江学者”和“国家杰青”为学科带头人，以科技创新团队、工程化、产业化为主体构架的高素质科技工程技术人员队伍和团队。
团队共承担国家973、863、国家重点研发计划、国家自然科学基金重点、面上和青年基金以及省部重大、重点项目等300余项，科研经费超过6亿元。共获得国家技术发明二等奖1项、国家自然科学二等奖2项、国家级教学成果一等奖和二等奖各1项、教育部自然科学一等奖1项、广东省技术进步一等奖2项等各类科技奖励20余项，在国内外重要学术期刊上发表科研论文600余篇，其中被SCI/EI收录论文400余篇。
团队依托生物医用材料与组织修复国家创新引智基地，与近20个国际顶尖的学术团队建立了高水平的国际合作，包括与新加坡南洋理工大学共建“中新国际研究院”（政府投入），与美国哥伦比亚大学、约翰霍普金斯大学、英国格拉斯哥等大学等进行合作研究、联合办学，建立了多元化人才培养机制。团队着力探索体制机制创新，建立“开放、多元、动态、高效”的协同创新模式；建立了广东省人体组织功能重建产学研创新联盟，并于2018年获批人体组织功能重建省部共建协同创新中心，医工研企政结合，建设集产品和技术研发—成果转化—产业化—检验检测—临床应用的全链条，有效缩短原创高端医疗器械的研发和转化周期，为国家医药健康领域的经济建设做出积极而重要的贡献。